Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mucodentol for COVID-19 symptoms
IRCT20200711048076N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Mucodentol in coronavirus disease 2019 (COVID-19), sponsored by Shahid Beheshti University of Medical Sciences. Started May 2020; status: completed.
02
Drugs
Mucodentol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200711048076N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200711048076N1.